Page 9 - Aggressive Behavior News Today

email article Physicians in general are a pretty intelligent group of professionals. However, we sometimes make the mistake of thinking that because we know a lot about one particular thing, we must also know a lot about almost everything. However, given the exploding pace of advancing knowledge, that idea is hubristic. But it isnt just science and technology where we fall short. During the COVID pandemic, one of the things most contentious has been the idea of churches meeting in person....

On April 10, 2020, MedPage Today published a story on the success seen with guselkumab (Tremfya) for psoriatic arthritis in two large pivotal phase III trials, DISCOVER-1 and DISCOVER-2. Guselkumab is a monoclonal antibody that binds the interleukin-23 p19 subunit, and was approved for use in psoriasis in July 2017. On July 14, 2020 the FDA approved guselkumab for psoriatic arthritis, based on the results of the DISCOVER trials. In DISCOVER-1, which included 381 patients with active psoriatic ...